4//SEC Filing
Blume-Jensen Peter 4
Accession 0000905148-24-003223
CIK 0001781174other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:26 PM ET
Size
8.1 KB
Accession
0000905148-24-003223
Insider Transaction Report
Form 4
Masson Kristina
DirectorEVP - Business Operations
Transactions
- Tax Payment
Common Stock
2024-11-14$7.92/sh−59,766$473,347→ 2,362,747 total - Tax Payment
Common Stock
2024-11-14$7.92/sh−490$3,881→ 316,756 total(indirect: See Footnote)
Blume-Jensen Peter
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2024-11-14$7.92/sh−490$3,881→ 316,756 total(indirect: See Footnote) - Tax Payment
Common Stock
2024-11-14$7.92/sh−59,766$473,347→ 2,362,747 total
Footnotes (3)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.
- [F2]These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.
- [F3]These securities are held by co-founder and EVP, Dr. Kristina Masson, who is also Dr. Blume-Jensen's spouse. Dr. Blume-Jensen disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Documents
Issuer
Acrivon Therapeutics, Inc.
CIK 0001781174
Entity typeother
Related Parties
1- filerCIK 0001950499
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 4:26 PM ET
- Size
- 8.1 KB